Please select the eligibility criteria that correspond to the clinical trial below.
Title: Efectiveness of a Cognitive Behavioral Intervention in Patients With Symptoms Somatization, as Measure Quality of Life, Front the Clinical Practice Usual Action in Primary Health Care. A Controlled Clinical Trial With Parallel Groups
Brief Summary: The purpose of this study is to evaluate the efectiveness of a behavioral cognitive grupal intervention (BCI) in patients with somatization symptoms which has an effect on the perceived quality of life front conventional intervention.


Options:
A: Inclusion Criteria:

* Multiple somatic symptoms from several organ systems, without adequate medical explanation.
* Moderate to severe influence on daily life.
* The disorder's functional component can easily be separated from a possible well-defined chronic somatic illness.
* No lifetime-diagnosis of psychoses, bipolar affective disorder or depression with psychotic symptoms (International Classification of Diseases \[ICD-10\]: F20-29, F30-31, F32.3, F33.3)
* The condition must have been present for at least 2 years.
* Patients of Scandinavian origin who understand, read, write and speak Danish.

Exclusion Criteria:

* No informed consent.
* An acute psychiatric disorder that demands other treatment, or if the patient is suicidal.
* Abuse of narcotics or alcohol and (non-prescribed) medicine.
* Pregnancy.
* Current industrial injury case or other action for damages.
B: Inclusion Criteria:

* Has received primary medical care at Harvard Vanguard Medical Associates (HVMA) for at least 12 months prior to study entry
* Expects to continue receiving care from the current primary care physician for at least the next 12 months
* Meets requirement for average hypochondriasis screening score
* Able to speak and read English
* Falls within the top 20% of utilizers of health care services in the HVMA system over the past year
* Has attended no more than one visit to any specialist over the year prior to study entry

Exclusion Criteria:

* Psychiatric illness (e.g., psychosis, dementia, suicidal ideation)
* Somatoform pain disorder or currently receiving treatment for somatoform pain disorder (e.g., relaxation training)
* History of alcohol or substance abuse or dependence within the 12 months prior to study entry
* Terminal medical illness or major medical illness expected to worsen significantly over the next year
* Ongoing symptom-contingent litigation against HVMA
* Monetary compensation for medical disability
C: Inclusion Criteria:

* Attending patients with 2 or more medically unexplained somatic symptoms during the last 6 months.
* Having came to medical examination on primary care at least 10 times during the last year.
* be able to follow the trial´s demands, not have plans for moving another place and understand the Spanish language.
* Patients who consent to take part.

Exclusion Criteria:

* Diagnostics on serious mental disorder.
* Suicidal intentions at the moment of getting involved in the study.
* Diagnostics on addiction to toxic substances.
* Diagnostics on well-known body illness responsible for the symptoms.
* Previous psychotherapy during the previous year.
D: Inclusion Criteria:

* Patients scoring \>= 5 on the Patient Health Questionnaire (German Version), corresponding to a probable or established diagnosis of Anxiety, Depression or Somatoform Disorder

Exclusion Criteria:

* Negation of Inclusion Criteria

Answer: C